The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Natural history of liver disease in cystic fibrosis
Abstract
The median age of the population with cystic fibrosis (CF) has increased worldwide, which has led to the suggestion that the prevalence of liver disease would increase. The aim of this study was to evaluate the natural history of CF-associated liver disease over a 15-year period in a well-controlled population of patients with CF. During the years 1976 through 1993, 124 patients were followed up by yearly liver function tests (LFTs). Fifteen patients were followed up with liver biopsies throughout the whole study period. More than 50% of the patients had pathological LFTs in infancy, later being normalized. Approximately 25% of children 4 years of age or older had biochemical markers of liver disease during the study period. In about 10% of the patients, cirrhosis or advanced fibrosis was confirmed at biopsy and 4% of patients had cirrhosis with clinical liver disease. Severe liver disease developed mainly during prepuberty and puberty. Of the 15 patients prospectively followed up with liver biopsies, only 3 had progressive fibrosis. No specific risk factor was identified, but deficiency of essential fatty acids was found more often in patients with marked steatosis (P < .05). No patient developed clinical liver disease in adulthood and the histological changes in the liver biopsies were usually not progressive. Liver disease was no more frequent at the end of the study period although the median age of the patient population had increased. Modern treatment might positively influence liver disease because it seemed less common, less progressive, and less serious than previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SHWACHMAN, H. (1958) · A.M.A. Journal of Diseases of Children · doi:10.1001/archpedi.1958.02060060008002 · Cited by 994
One-Second Needle Biopsy of the Liver
Menghini, G. (1958) · Gastroenterology · doi:10.1016/s0016-5085(19)35563-5 · Cited by 381
Vitamin A Transport in Human Vitamin A Toxicity
Smith, F. R., & Goodman, D. S. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604082941503 · Cited by 316
Bedossa, P., Houglum, K., Trautwein, C., Holstege, A., & Chojkier, M. (1994) · Hepatology · doi:10.1002/hep.1840190527 · Cited by 249
Analysis of risk factors for the development of liver disease associated with cystic fibrosis
Colombo, C., Apostolo, M. G., Ferrari, M., Seia, M., Genoni, S., Giunta, A., & Sereni, L. P. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70361-2 · Cited by 189
Lindblad, A., Glaumann, H., & Strandvik, B. (1998) · Hepatology · doi:10.1002/hep.510270126 · Cited by 175
Self-citationSeverity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation
Johansen, H. K., Nir, M., Koch, C., Schwartz, M., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)92449-c · Cited by 164
BLANC, W. A., & SANT'AGNESE, P. A. D. (1956) · PubMed · Cited by 151
A DISTINCTIVE TYPE OF BILIARY CIRRHOSIS OF THE LIVER ASSOCIATED WITH CYSTIC FIBROSIS OF THE PANCREAS
di Sant'Agnese, P. A., & Blanc, W. A. (1956) · PEDIATRICS · doi:10.1542/peds.18.3.387 · Cited by 140
ALUNPHILLIPS, T. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90523-1 · Cited by 125
Winklhofer‐Roob, B. M. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13229.x · Cited by 102
Liver transplantation for hepatic cirrhosis in cystic fibrosis.
Noble-Jamieson, G., Barnes, N. D., Jamieson, N. V., Friend, P. J., & Calne, R. (1996) · PubMed Central · Cited by 98
Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis
Portal, B., Richard, M., Faure, H., Hadjian, A. J., & Favier, A. E. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.843 · Cited by 90
Apparent Potentiation of Acetaminophen Hepatotoxicity by Alcohol
LICHT, H., SEEFF, L. B., & ZIMMERMAN, H. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-511_1 · Cited by 88
Home intravenous antibiotic treatment of patients with cystic fibrosis
Strandvik, B., Hjelte, L., Malmborg, A.-S., & Widén, B. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12239.x · Cited by 88
Self-citationAmoxicillin-clavulanate potassium-associated cholestasis
Reddy, K. R., Brillant, P. T., & Schiff, E. R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91633-8 · Cited by 87
Liver transplantation for hepatic cirrhosis in cystic fibrosis.
Noble-Jamieson, G., Valente, J., Barnes, N. D., Friend, P. J., Jamieson, N. V., Rasmussen, A., & Calne, R. Y. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.71.4.349 · Cited by 86
Duthie, A., Doherty, D. G., Williams, C., Scott-Jupp, R. H., Warner, J. O., Tanner, S. M., Williamson, R., & Mowat, A. P. (1992) · Hepatology · doi:10.1002/hep.1840150418 · Cited by 83
Biliary complications of cystic fibrosis.
O'Brien, S. A., Keogan, M. T., Casey, M., Duffy, G., McErlean, D., FitzGerald, M. X., & Hegarty, J. E. (1992) · Gut · doi:10.1136/gut.33.3.387 · Cited by 79
Trimethoprim-Sulfamethoxazole-Induced Intrahepatic Cholestasis
NAIR, S. S., KAPLAN, J. M., LEVINE, L. H., & GERACI, K. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-511_2 · Cited by 44
Urinary Bile Acid Excretion in Correlation to Liver Histopathology in Cystic Fibrosis
Arborgh, B., Eklund, A., Norman, A., et al. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181435 · Cited by 21
Role of vitamin A in liver fibrosis
Knook, D. L., Bosma, A., & Seifert, W. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01797.x · Cited by 18
Fasting Serum Bile Acid Levels in Relation to Liver Histopathology in Cystic Fibrosis
Strandvik, B., & Samuelson, K. (1985) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528509091668 · Cited by 18
Self-citation
Cited by
Turck, D., Braegger, C. P., Colombo, C., Declercq, D., Morton, A., Pancheva, R., Robberecht, E., Stern, M., Strandvik, B., Wolfe, S., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.004 · Cited by 526
Self-citationNutrition in patients with cystic fibrosis: a European Consensus
Sinaasappel, M., Stern, M., Littlewood, J., Wolfe, S., Steinkamp, G., Heijerman, H. G. M., Robberecht, E., & Döring, G. (2002) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00032-2 · Cited by 477
Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease
Debray, D., Kelly, D., Houwen, R., Strandvik, B., & Colombo, C. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60006-4 · Cited by 432
Self-citationLiver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome
Colombo, C., Battezzati, P. M., Crosignani, A., Morabito, A., Costantini, D., Padoan, R., & Giunta, A. (2002) · Hepatology · doi:10.1002/hep.1840360613 · Cited by 377
Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis
Sun, X., Sui, H., Fisher, J. T., Yan, Z., Liu, X., Cho, H.-J., Joo, N. S., Zhang, Y., Zhou, W., Yi, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43052 · Cited by 366
Metadata
- Authors
- Lindblad, A., Glaumann, H., & Strandvik, B.
- Venue
- Hepatology
- Published
- 1999-11
- Volume
- 30
- Issue
- 5
- Pages
- 1151-1158
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2170885242
- Cited by
- 306
- References
- 23
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.